Nexgel NXGL
NASDAQ NXGL
$0.17 -0.01 (-5.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nexgel (NXGL) EPS (Basic) (2018 - 2026)

Updated

Nexgel (NXGL) reported EPS (Basic) of -$0.40 for Q2 2026, compared with -$0.09 a year earlier.

Analysis

Nexgel (NXGL) EPS (Basic) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nexgel's EPS (Basic) came in at -$0.66; for FY2025, it came in at -$0.38.

  • By year, EPS (Basic) came in at -$0.50 in FY2024, -$0.56 in FY2023, -$0.85 in FY2022 and -$1.45 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Iqvia Holdings 44.26 Bn 36.10 Bn 1.44 Bn 1.54
2 Medpace Holdings 17.42 Bn 15.48 Bn 201.64 Mn 4.31
3 Charles River Laboratories International 14.08 Bn 13.32 Bn 363.37 Mn -0.03
4 Icon 13.02 Bn 10.12 Bn 479.29 Mn 0.93
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn -0.14
6 Ginkgo Bioworks Holdings 817.41 Mn 55.33 Mn 18.44 Mn -0.75
7 Evotec SE 608.00 Mn -965.22 Mn - -
8 Champions Oncology 69.59 Mn 45.24 Mn 7.70 Mn -0.03
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn -0.09
10 Nexgel 1.65 Mn -2.26 Mn 1.11 Mn -0.40
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.40
Dec 31, 2025 -0.12
Sep 30, 2025 -0.08
Jun 30, 2025 -0.09
Mar 31, 2025 -0.09
Dec 31, 2024 -0.13
Sep 30, 2024 -0.11
Jun 30, 2024 -0.14
Mar 31, 2024 -0.14
Dec 31, 2023 -0.19
Sep 30, 2023 -0.10
Jun 30, 2023 -0.12
Mar 31, 2023 -0.15
Dec 31, 2022 -0.12
Sep 30, 2022 -0.22
Jun 30, 2022 -0.19
Mar 31, 2022 -0.33
Dec 31, 2021 -0.55
Sep 30, 2021 -0.38
Jun 30, 2021 -0.28
API Access

Nexgel EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=NXGL&period=max&api_key=YOUR_API_KEY